Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency

Iismaa, 2009, Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders, Physiol. Rev., 89, 991, 10.1152/physrev.00044.2008 Tatsukawa, 2016, Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death, Cell Death Dis., 7, e2244, 10.1038/cddis.2016.150 Brown, 2013, Transglutaminase 2 and NF-kappaB: an odd couple that shapes breast cancer phenotype, Breast Canc. Res. Treat., 137, 329, 10.1007/s10549-012-2351-7 Wang, 2012, TG2, a novel extracellular protein with multiple functions, Amino Acids, 42, 939, 10.1007/s00726-011-1008-x Jin, 2011, Activation of extracellular transglutaminase 2 by thioredoxin, J. Biol. Chem., 286, 37866, 10.1074/jbc.M111.287490 Akimov, 2000, Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin, J. Cell Biol., 148, 825, 10.1083/jcb.148.4.825 Cardoso, 2015, Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies, FEBS J., 282, 2063, 10.1111/febs.13276 Nanda, 2001, Targeted inactivation of Gh/tissue transglutaminase II, J. Biol. Chem., 276, 20673, 10.1074/jbc.M010846200 Mearns, 2002, Impaired wound healing and altered fibroblast cytoskeletal dynamics in Gh knockout mice, Minerva Biotecnol., 14, 218 Bakker, 2006, Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII 1, Circ. Res., 99, 86, 10.1161/01.RES.0000229657.83816.a7 Bains, 2013, Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age, Rejuvenation Res., 16, 495, 10.1089/rej.2013.1452 Williams, 2010, Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse, Atherosclerosis, 210, 94, 10.1016/j.atherosclerosis.2009.11.014 Van Herck, 2009, Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice, J. Vasc. Res., 47, 231, 10.1159/000255966 Adany, 2003, Factor XIII subunit A as an intracellular transglutaminase, Cell. Mol. Life Sci., 60, 1049, 10.1007/s00018-003-2178-9 Beckers, 2017, Cre/lox studies identify resident macrophages as the major source of circulating coagulation factor XIII-A, Arterioscler. Thromb. Vasc. Biol., 37, 1494, 10.1161/ATVBAHA.117.309271 Muszbek, 2011, Factor XIII: a coagulation factor with multiple plasmatic and cellular functions, Physiol. Rev., 91, 931, 10.1152/physrev.00016.2010 Souri, 2008, Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII, Thromb. Haemost., 99, 401, 10.1160/TH07-10-0599 Koseki-Kuno, 2003, Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages, Blood, 102, 4410, 10.1182/blood-2003-05-1467 Pawlinski, 2002, Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction, Proc. Natl. Acad. Sci. U. S. A, 99, 15333, 10.1073/pnas.242501899 Pawlinski, 2007, Role of cardiac myocyte tissue factor in heart hemostasis, J. Thromb. Haemost., 5, 1693, 10.1111/j.1538-7836.2007.02649.x Noll, 1999, Effect of factor XIII on endothelial barrier function, J. Exp. Med., 189, 1373, 10.1084/jem.189.9.1373 Talman, 2016, Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration, Cell Tissue Res., 365, 563, 10.1007/s00441-016-2431-9 Ganame, 2009, Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction, Eur. Heart J., 30, 1440, 10.1093/eurheartj/ehp093 Gao, 2017, Microvascular leakage in acute myocardial infarction: characterization by histology, biochemistry, and magnetic resonance imaging, Am. J. Physiol. Heart Circ. Physiol., 312, H1068, 10.1152/ajpheart.00073.2017 Szondy, 2017, Transglutaminase 2 in human diseases, Biomedicine, 7, 15, 10.1051/bmdcn/2017070315 Wang, 2018, Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor, Cell Death Dis., 9, 613, 10.1038/s41419-018-0573-2 Al Jallad, 2006, Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures, Matrix Biol., 25, 135, 10.1016/j.matbio.2005.11.001 Mousa, 2017, Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow, Cell Death Differ., 24, 844, 10.1038/cdd.2017.21 Lauer, 2002, Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit, Thromb. Haemost., 88, 967, 10.1055/s-0037-1613342 Cordell, 2015, Normal bone deposition occurs in mice deficient in factor XIII-A and transglutaminase 2, Matrix Biol., 43, 85, 10.1016/j.matbio.2015.02.001 Iismaa, 2013, Glucose homeostasis in mice is transglutaminase 2 independent, PLoS One, 8, 10.1371/journal.pone.0063346 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Bond, 2011, The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture, J. Biomed. Biotechnol., 2011, 379069, 10.1155/2011/379069 Boisvert, 2006, Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size, Arterioscler. Thromb. Vasc. Biol., 26, 563, 10.1161/01.ATV.0000203503.82693.c1 Wolfer, 2002, Knockout mice: simple solutions to the problems of genetic background and flanking genes, Trends Neurosci., 25, 336, 10.1016/S0166-2236(02)02192-6 Doetschman, 2009, Influence of genetic background on genetically engineered mouse phenotypes, Methods Mol. Biol., 530, 423, 10.1007/978-1-59745-471-1_23 Hafezi-Moghadam, 2007, ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage, Am. J. Physiol. Cell Physiol., 292, C1256, 10.1152/ajpcell.00563.2005 Krasemann, 2017, The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases, Immunity, 47, 566, 10.1016/j.immuni.2017.08.008 Levy, 2015, Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration, EMBO Mol. Med., 7, 211, 10.15252/emmm.201404524 Huang, 2010, Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy?, Nephrol. Dial. Transplant., 25, 3897, 10.1093/ndt/gfq291 Fisher, 2009, Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarring, Matrix Biol., 28, 20, 10.1016/j.matbio.2008.10.003 Bernassola, 2002, Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient, FASEB J., 16, 1371, 10.1096/fj.01-0689com Sarvary, 2004, Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis, Cell. Immunol., 228, 81, 10.1016/j.cellimm.2004.04.007 Matlung, 2009, Calcification locates to transglutaminases in advanced human atherosclerotic lesions, Am. J. Pathol., 175, 1374, 10.2353/ajpath.2009.090012 Haroon, 2001, Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression, Lab. Investig., 81, 83, 10.1038/labinvest.3780214 Hansson, 2015, Inflammation and plaque vulnerability, J. Intern. Med., 278, 483, 10.1111/joim.12406 Orban, 2004, Crosslinking of collagen gels by transglutaminase, J. Biomed. Mater. Res. A, 68, 756, 10.1002/jbm.a.20110 Ma, 2018, Cardiac fibrosis: new insights into the pathogenesis, Int. J. Biol. Sci., 14, 1645, 10.7150/ijbs.28103 Carcao, 2018, Recombinant FXIII (rFXIII-A2) prophylaxis prevents bleeding and allows for surgery in patients with congenital FXIII A-subunit deficiency, Thromb. Haemost., 118, 451, 10.1055/s-0038-1624581 Heidt, 2014, Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction, Circ. Res., 115, 284, 10.1161/CIRCRESAHA.115.303567 Small, 1999, Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation, J. Biol. Chem., 274, 21291, 10.1074/jbc.274.30.21291